The TLR pathway, through signaling by the myeloid differentiation primary response gene 88 (MyD88)-dependent pathway, increases the risk of colitis (or other inflammatory bowel diseases; IBDs)-associated CRC due to commensal gut microbiota [20–22]. This evidence concerns the gene MYD88 and colitis.